Henan Lingrui Pharmaceutical Co., Ltd. (HENAN LINGRUI PHARMACEUTICAL) aksje

Henan Lingrui Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of drugs in China. It operates through Pharmaceutical and Healthcare Division; and Others segments. The company offers its products in ten dosage forms, such as adhesive plasters, tablets, capsules, granules, and tinctures, etc. for various indications, including orthopedic, cardiovascular, cerebrovascular, dermatology, pediatrics, respiratory, and anesthesiology. Its products include Tongluoqutong plasters, Peiyuantongnao capsules, Danlutongdu tablets, stomachache free tablets, and Shenqi Hypoglycemic capsules; and Tongluo pain relief creams, Huoxuexiaotong tinctures, bone strengthening musk pain relief creams, indomethacin patches, abdominal soothing plasters, children's paracetamol and phenylephrine granules, children's kechuanling granules, montmorillonite powders, medical cooling patches, three yellow pearl creams, mometasone furoate creams, mupirocin ointments, bluestone particles, ke ning capsules, xiao chaihu tablets, and ruishuan fentanyl transdermal patches. The company also engages in industrial and real estate investment; technology research and development; ecological agriculture; and high-tech activities. Henan Lingrui Pharmaceutical Co., Ltd. was founded in 1992 and is headquartered in Xinyang, China.